GlassScriptPhysician profile
Casser Farishta
NPI 1811566821
$5,289.47
in general payments reported to CMS, 2019-2025
13 companies · $2,634 in 2025
The $2,634 reported for 2025 was more than what 92% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $220 · 2022: $184 · 2023: $521 · 2024: $1,730 · 2025: $2,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,796 · Travel and Lodging: $2,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,796.39 |
| Travel and Lodging | $2,088.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,877.67 | 2021-2025 | Ortholoc 3di, Ortholoc 2 Lapifuse, Prostep Mica |
| Vilex LLC | $1,420.12 | 2025 | Hintermann |
| Treace Medical Concepts, INC. | $263.13 | 2025 | |
| Medtronic, INC. | $198.94 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Paratek Pharmaceuticals, INC. | $121.20 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $104.09 | 2024-2025 | Uni Cp, Grafix Pl, Stravix Pl |
| Bioventus LLC | $84.65 | 2025 | Exogen Ultrasound Bone Healing System |
| Pylant Medical | $64.78 | 2024-2025 | |
| Linvatec Corporation | $51.55 | 2025 | Neospan |
| Mimedx Group, INC. | $47.66 | 2025 | |
| Becton, Dickinson and Company | $24.32 | 2025 | Lifestream |
| Advanced Oxygen Therapy INC. | $17.88 | 2024 | Topical Oxygen Chamber For Extremities |
| Paragon 28, INC. | $13.48 | 2023 | Activcore Nail |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casser Farishta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.